Drug Profile


Alternative Names: YH-439

Latest Information Update: 08 Nov 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Yuhan
  • Class Hepatoprotectants; Small molecules; Thiazoles
  • Mechanism of Action Lipid peroxidation inhibitors; Protein synthesis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Cancer; Hepatitis B

Most Recent Events

  • 08 Nov 2010 Discontinued - Phase-II for Hepatitis B in Germany (PO)
  • 08 Nov 2010 Discontinued - Phase-II for Hepatitis B in South Korea (PO)
  • 08 Nov 2010 Discontinued - Preclinical for Cancer (Prevention)/Chemoprevention in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top